T he ocular surface, lined by corneal and conjunctival epithelia, can actively absorb Na ϩ from and secrete Cl Ϫ into the tear film (reviewed by Dartt 1 and Candia 2 ). The relative magnitudes of net Na ϩ absorption and Cl Ϫ secretion largely dictate the direction and magnitude of fluid movement across the ocular surface. A quantitative, mechanistic understanding of ocular surface ion transport is important in understanding the pathophysiology of dry eye conditions, or keratoconjunctivitis sicca (KCS), and in identifying targets for development of therapies to treat KCS. At present, INS365, a uridine triphosphate (UTP) agonist that stimulates chloride-fluid secretion through as yet unidentified channels, is in phase III clinical trials for treatment of KCS. 3 The purpose of this study was to establish, through experimental electrical potential measurements and mathematical modeling, a quantitative description of ion transport at the ocular surface.
We recently introduced an open-circuit potential difference (PD) method to study ion transport at the ocular surface in vivo. 4 In this method, electrical potentials generated at the superfused ocular surface (with respect to the body) are measured by a high-impedance voltmeter in response to ion substitution, agonist-inhibitor addition, or other maneuvers. Surface PDs arise from polarized ion conductances in apical and basolateral membranes across tight epithelia and so can provide, in principle, quantitative information about electrogenic transporting systems. The corneal and conjunctival surfaces are superfused as a single compartment in this method to mimic native tear film physiology, allowing assessment of the relative contributions of individual transporters to tear film homeostasis. In our initial study, CFTR was identified as a major route for Cl Ϫ secretion across the ocular surface into the tear film, and CFTR activators were proposed as a possible therapy for dry eye conditions.
In the current study, we extend the initial experimental analysis of ocular surface Cl Ϫ transport to include Na ϩ -transporting mechanisms and, by mathematical modeling, to assess the contributions of individual ion transporting pathways to net solute and fluid movement across the ocular surface. Prior experimental data with regard to Na ϩ channels include shortcircuit current experiments on in vitro albino rabbit cornea and conjunctiva, where amiloride-sensitive Na ϩ conductance could not be demonstrated. 5, 6 However, short-circuit measurements on excised bovine cornea, 7 and more recently on primary cultures of rabbit corneal epithelium, 8 have provided functional evidence for amiloride-sensitive channels. Of potential relevance to human ocular disorders, the epithelial Na ϩ channel (ENaC) subunit proteins have been localized to the apical membrane of human corneal epithelium. 9 In this study, ocular surface PDs were used to identify and characterize Na ϩ channel and Na ϩ -coupled glucose-and amino acid-transporting pathways at ocular surface epithelia in living mice. A model of ocular surface epithelial ion transport was developed to compare quantitatively the rates of Na ϩ absorption versus Cl Ϫ secretion and to analyze mechanisms of proposed coupling between CFTR and ENaC. 10, 11 Modeling computations were applied to test the hypotheses that ENaC provides a quantitatively significant mechanism for ocular surface fluid transport that may be exploited for therapy of KCS and that enhanced Na ϩ absorption in CF mice can be accounted for by CFTR-ENaC electrochemical coupling. The mathematical model describing ocular surface epithelial transport is an extension of prior models developed by our laboratory and others for non-ocular epithelial ion transport. [12] [13] [14] Figure 1 diagrams the transporting systems and pathways included in the model. The model allowed the computation of epithelial cell membrane potentials and currents, transepithelial water flow, and cellular [Na
and volume in response to experimental maneuvers such as transporter activation-inhibition and ion substitution. Although such an epithelial transport model contains multiple parameters, constraints imposed by experimental observations allowed little freedom in selecting model parameters. The model was able to reproduce experimental findings closely and to provide quantitative information and insights not otherwise possible.
METHODS

Mice
Wild-type and CF mice (homozygous ⌬F508 mutant mice) 15 on a CD1 genetic background were bred and cared for at the University of California, San Francisco, Animal Facility. Wild-type mice were fed a standard diet, and CF mice were fed a nutritional supplement (Peptamen; Nestlé, Vevey, Switzerland). Mice aged 8 to 12 weeks weighing 25 to 30 g were used. Protocols were approved by the University of California, San Francisco, Committee on Animal Research and were in compliance with the ARVO Statement for the Use of Animals in Ophthalmic and Vision Research.
Mice were anesthetized with 125 mg/kg 2,2,2-tribromoethanol (Avertin; Sigma-Aldrich, St. Louis, MO) intraperitoneally, with supplementation during experiments to maintain deep anesthesia. Mice were immobilized, with the eye under study oriented to face upward in a custom-built stereotaxic device equipped with a rotating jaw clamp. Corneas were kept hydrated with isosmolar saline (PBS with NaCl added to give 320 mOsM) before measurements began. Core temperature was monitored with a rectal probe and maintained at 37 Ϯ 1°C with a heating pad.
Measurement of Ocular Surface PD
PD was measured continuously, with the ocular surface perfused serially with different solutions, as described in detail previously. 4 Briefly, solutions were perfused at 6 mL/min through plastic tubing using a multireservoir gravity pinch-valve system (ALA Scientific, Westbury, NY) and a variable-flow peristaltic pump (medium flow model; Fisher Scientific, Fair Lawn, NJ). An ϳ50-L fluid reservoir was maintained at the ocular surface by surface tension, with the probe catheter (PE-90 polyethylene tubing) fixed ϳ1 mm from the eye surface by a micropositioner and a suction cannula positioned ϳ3 mm from the orbit. Solution exchange time was generally less than 3 seconds. The measuring and reference electrodes consisted of Ag/AgCl with 1-M KCl agar bridges. The measuring electrode was located near the catheter probe and connected to a high-impedance digital voltmeter (IsoMillivolt Meter; World Precision Instruments, Sarasota, FL), having input and system electrical resistances of 10 12 and 1.1 ϫ 10 6 ⍀, respectively. The reference electrode was connected via a continuous liquid (320 mOsM saline) column to a winged, 21-gauge needle inserted in the subcutaneous tissue at the back of the neck. PDs were recorded at 5 Hz with a 14-bit analog-to-digital converter.
Solutions and Compounds
All perfusion solutions were isosmolar to mouse serum (320 Ϯ 5 mOsM) as measured by freezing point-depression osmometry (Precision Systems, Inc., Natick, MA). Solution compositions are listed in Table 1 . Solution 1 (control solution) was PBS supplemented with 30 mOsM NaCl. Solution 2 (Na ϩ -free solution) was made by replacing NaCl with choline chloride and Na 2 HPO 4 with 8 mM phosphoric acid, titrating to pH 7.4 with choline base and then adding choline chloride to achieve 320 mOsM. Compounds were purchased from Sigma-Aldrich unless indicated otherwise. Inhibitors, activators, and substrates used in the perfusates included amiloride or benzamil (0.1-100 M), phloridzin (100 M), forskolin (10 M), and L-arginine or glycine (0.1-10 mM, freshly dissolved in perfusate). CFTR inh -172 (3-[(3-trifluoromethyl)phenyl]-5-(3-carboxyphenyl) methylene]-2-thioxo-4-thiazolidinone; 10 M) was synthesized as described. 16 In protocols in which solution 5 (low-Cl 4 Inhibitorsactivators were prepared as 1000ϫ stock solutions in dimethyl sulfoxide (DMSO), unless otherwise indicated. Paracellular pathways for all charged species (transporters 10 -14) are also included. Although cellular pH regulation may be important in cornea and conjunctiva, bicarbonate and proton transport pathways are not considered significant determinants of ocular surface fluid transport, as seen by the small, ϳ2-mV bicarbonate effect on ocular PD. 4 As such, bicarbonate transport and Na ϩ /H ϩ exchange pathways are not included in this model. Table   2 . Transporter permeability coefficients were determined from opencircuit ion flux and membrane potential data (see Tables A1 and A2 in the Appendix) deduced from measured ocular PDs and literature values, as explained in the Appendix. Solute activities were related to absolute concentrations and osmotic activities according to intracellular and extracellular activity and osmotic coefficients, as listed in Table A3 .
PD Protocols and Data Analysis
Parameters. Definitions and units of symbols are listed in
Solute flux (J i X ) through each membrane and paracellular transport pathway was defined as a function of solute concentrations on each side of the membrane and, if electrogenic, a membrane potential. Electrodiffusive flux of solute X through the ith transport pathway was assumed to be nonsaturable and nonallosteric, unless otherwise noted, as given by the Goldman-Hodgkin-Katz equation:
where P i is the permeability coefficient (in centimeters per second), z i is the ionic charge, and X 1 and X 2 are the activities of transported solute (in millimolar) in compartments to the left and right of the diffusive barrier, respectively. U z , the dimensionless membrane potential, is related to the appropriate potential difference ( z ) in Table 2 . Equations for flux through each transport pathway ( J i X ), and the resultant net apical, basolateral, and paracellular currents (I a , I b , and I p ) are provided in the Appendix (equations A1-A17).
Numerical Solution. Cell membrane potentials at time (t ϩ ⌬t)
were calculated iteratively with the Newton-Raphson method based on electroneutral conditions. The open-circuit model requires equal opposing transcellular and paracellular currents (I a ϭ I b ϭ ϪI p ). An option was included to model transport under short-circuit conditions, where I a ϭ I b and U a ϭ U b . U a and U b were computed iteratively by user-supplied initial guess. Assuming instantaneous osmotic equilibration and constant cell surface area, cell height h͑t ϩ ⌬t͒ (in micrometers) was computed as
⌺ aϪb x J i X generically represents the net osmotic flux (in milliosmolar per square centimeter per second) into the cell and is related to individual transporter fluxes in equation A18. s is mouse serum osmolarity (in milliOsmols per cubic centimeter). Intracellular solute activities were computed from fluxes and the updated cell height from equation 2 according to
⌺a x J i X is defined as the net rate of entry of active solute X (in 10   4 meq/cm 2 per second) into the cellular compartment through the various transporters. Refer to equations A19 -A22 for the specific expressions used in computing Na ϩ ͑t ϩ ⌬t͒, K ϩ ͑t ϩ ⌬t͒, Cl Ϫ ͑t ϩ ⌬t͒, and org͑t ϩ ⌬t͒. The model also offers the option to impose brief current or voltage spikes (one each minute) to compute total tissue resistance. The observed change in voltage or current can be used to monitor transepithelial electrical resistance (TEER, in kilo-ohms per square centimeter) under open-or short-circuit conditions, respectively (TEER ϭ ⌬ t /⌬I a ). Though the exact mechanism of transepithelial fluid movement remains controversial, it is agreed that it results in nearisosmolar water flux driven by solute transport. As such, net transepithelial water secretion or absorption (microliters per square centimeter per hour) was computed assuming isosmolar fluid flow across the apical membrane and paracellular tight-junctional barrier by
where ⌺ aϩp x J i X is the net osmotic flux (in milliOsmols per square centimeter per second) into the apical compartment from individual transport pathway fluxes (equation A23), and s is serum osmolarity (in Osmols per liter).
RESULTS
Amiloride-Sensitive Na
؉ Transport Na ϩ channel function was studied by using ion replacement and transporter substrates and inhibitors. Baseline PD was first established (using solution 1) before replacement of perfusate Na ϩ by the relatively impermeant cation choline (solution 2). This exchange produced a 5-to 10-mV depolarization that was reversed by reintroduction of Na ϩ (solution 1). Representative PD recordings in Figure 2A show the reversible changes in PD on Na ϩ substitution, depolarization by amiloride (100 M) in the presence of a Na ϩ -containing perfusate (left), and blocking of the Na ϩ -induced hyperpolarization by amiloride (right). Dose-inhibition studies were performed for amiloride and its analogue, benzamil. A representative dose-response curve for amiloride is shown in Figure 2B (left). K i was 0.82 M for amiloride and 0.22 M for benzamil (right). These data indicate the involvement of amiloride-and benzamil-sensitive Na ϩ channel(s) in ocular surface Na ϩ absorption, which is probably ENaC.
To determine the contribution of the other major cation K ϩ to apical electrogenic transport, experiments were performed using a high-K ϩ solution (solution 6). Amiloride was first added to solution 1 to minimize the influence of Na ϩ channel function on interpretation of PDs in terms of K ϩ channel function. Switching to solution 6 produced a very small 1-to 2-mV reversible hyperpolarization (data not shown, n ϭ 5 separate experiments). Model computations supported the conclusion that apical K ϩ conductance is much lower than apical Na ϩ or Cl Ϫ conductance. Ion Transport in CF Mice. Ocular surface Cl Ϫ transport was assayed as described previously.
4 Figure 3A shows PD data from wild-type versus CF mice in which baseline PDs (of similar values) were first recorded with solution 1. Switching to an amiloride-containing solution depolarized ocular surface PDs, with CF mice showing a significantly greater response (15-20 mV in CF vs. 5-10 mV in wild-type mice). Replacing most Cl Ϫ by the relatively impermeant anion gluconate (solution 5) gave a sustained hyperpolarization in wild-type but not CF mice, which is related to cAMP-but not CFTR-independent Cl Ϫ secretion. The CFTR agonist forskolin produced a further hyperpolarization in wild-type mice that was reversed by CFTR inh -172.
The protocol used in Figure 2A was applied to investigate amiloride-sensitive Na ϩ conductance in CF mice. Representative PD recordings in Figure 3B (left) show reversible depolarizations in wild-type and CF mice in response to Na ϩ substitution. Depolarizations of similar magnitude were produced by amiloride (100 M) in the presence of Na ϩ -containing perfusate. The CF mice consistently showed greater responses than wild-type mice to both Na ϩ replacement and amiloride addition. As summarized in Figure 3B (right), Na ϩ replacement and amiloride administration produced ⌬PDs of 20 Ϯ 3 and 19 Ϯ 2 mV, (SE, n ϭ 6) in CF mice, respectively. The same maneuvers produced 6 Ϯ 2-and 7 Ϯ 1-mV depolarizations in wild-type mice (n ϭ 6). These results indicate the presence of an amiloride-sensitive Na ϩ channel at the ocular surface, with apparent increased activity in CF mice.
Modeling Ocular Surface Na ؉ and Cl ؊ Transport. The PD measurements suggest that active Na ϩ and Cl Ϫ transport processes dictate net fluid movement across corneal-conjunctival epithelia, and comparative experiments performed on wild-type versus CF mice suggest a complex interaction among 
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these pathways. As such, we developed a model to gain better qualitative understanding and to define quantitatively the key determinants of active ocular surface fluid secretion. According to the model in Figure 1 with parameters for the ocular surface of wild-type mice selected as described in the Appendix, Figure 4A shows the time course of the major cellular variables in mice after "inhibition" (by amiloride) of transporter 1 (ENaC conductance). Before inhibition, all parameters were stable to within 0.01% for a 60-minute simulation (not shown). The top graph shows the time-dependent apical, basolateral, and transepithelial potentials ( a , b , and PD). Conductances were chosen to give a baseline PD of Ϫ23 mV and a ratio of active Na ϩ to Cl Ϫ flux of 1:1, which produced a 5.5-mV amiloride-induced PD depolarization. The second graph shows total transepithelial current before and after amiloride. The steady-state current of 8.0 A/cm 2 was reduced by 22% by ENaC inhibition. The current spikes produced by the periodic brief voltage spikes gave a baseline TEER of 5.3 k⍀/cm 2 , which increased to 6.8 k⍀/cm 2 after amiloride addition. The bottom two panels in Figure 4A show the influence of apical Na ϩ conductance on the three major intracellular ions and cell height. There was a small decrease in cell height consequent to reduced cellular Na ϩ . Secondarily enhanced transport of K ϩ into the cell produced a small 0.4% final increase in cell height. In general, each cell parameter reached a new steady state within minutes after inhibition of transporter 1. Figure 4B shows the time-dependent PD response in opencircuit conditions after a series of maneuvers commonly used to elucidate transport mechanisms. As seen in the top graph, simulated Na ϩ replacement by choline yielded a depolarization similar to the experimental findings in Figures 2A and 3B . The immediate and sustained hyperpolarization of 9.5 mV predicted on replacing most apical Cl Ϫ with gluconate (solution 1 switched to solution 5) also replicated experimental trends. The bottom two panels predict the time course of PD reduction toward zero after basolateral inhibition of the lone source of cellular Cl Ϫ , the Na ϩ /K ϩ /2Cl Ϫ symporter (transporter 6), and the transepithelial current generator, the 3Na ϩ /2K ϩ ATPase (transporter 7). Because the electroneutral Na ϩ /K ϩ /2Cl Ϫ symporter lacks a membrane-potential dependence, no immediate change in PD was present on its inhibition.
The main findings from ocular PD experiments were modeled. In Figure 5A , the protocol for studying chloride transport was simulated, with initial ENaC inhibition, followed serially by switching to a low-Cl Ϫ solution, addition of a CFTR activator, and then addition of a CFTR inhibitor. This simulation resembled experimental PD data (as in Fig. 3A, top) with one exception. Simulated instantaneous Cl Ϫ channel activation yielded a significant transient hyperpolarization followed by more modest sustained hyperpolarization. Such PD behavior is not seen experimentally in response to either forskolin or direct CFTR activators, but is observed after addition of UTP. 4 Of note, incorporating rectification into the basolateral K ϩ channel Direct CFTR activators and the general cAMP agonist forskolin have been found to elicit nearly identical diffusion potentials under low-Cl Ϫ conditions. 4 To test whether isolated CFTR activation can be predicted to enhance apical Cl Ϫ secretion in a manner similar to forskolin, simulations were performed in which basolateral K ϩ (transporter 8) conductance was activated to various degrees along with CFTR. Indeed, only a small augmentation of CFTR-activator-induced hyperpolarization could be achieved by concurrent stimulation of basolateral K ϩ conductance (-35.4-mV PD after threefold CFTR and K ϩ channel activation vs. Ϫ34.4 mV for CFTR activation alone, not shown). These findings have implications regarding strategies of pharmacological modulation of fluid secretion (see the Discussion section).
The simulation in Figure 5B focused on the difference in amiloride effect in wild-type versus CF mice (as seen in Figs. 3A, 3B) and the possibility of CFTR-ENaC interactions. Model parameters for wild-type and CF mice were chosen to yield identical baseline PDs of -23 mV, as reported previously 4 and depicted in Figure 3B . Apical Cl Ϫ permeability in CF mice was chosen to be 20% of that in wild-type mice, to recapitulate the observed amiloride effect in CF mice whereas Na ϩ conductance was fixed to that in wild-type mice. As seen in Figure 5B , PD depolarized by 14.5 mV upon ENaC inhibition in CF mice, similar to that measured in Figure 3B . Switching the apical compartment to a low-Cl Ϫ solution (solution 5) correctly predicted a small diffusion potential of 2.1 mV in CF mice, compared with the 8.7-mV hyperpolarization in wild-type mice. Simulations were also performed in which ENaC permeability was increased twofold (using parameters from CF or wild-type mice), examining effects of ENaC inhibition and low-Cl Ϫ substitution. ENaC inhibition yielded depolarizations of 19 and 10 mV with CF and wild-type parameters, respectively, and hyperpolarizations of 4.1 and 8.8 mV for low Cl Ϫ . In both cases, ENaC hyperactivity produced substantial low-Cl Ϫ effects, which was inconsistent with experimental findings. Of importance, the model reproduced the major ocular surface electrophysiological properties in wild-type and CF mice only in the absence of CFTR-dependent ENaC conductance (see the Discussion section).
By assuming isosmolar fluid secretion, implying fixed coupling between transepithelial solute and water transport, we also modeled the ability of transporter modulators to increase transepithelial water secretion. Computations were performed under physiological conditions (in the absence of transepithelial ionic gradients) to simulate compound action on fluid secretion into the native tear film. Figure 5C shows that both ENaC inhibition and CFTR activation increased net fluid secretion by inhibiting Na ϩ absorption and enhancing Cl Ϫ secretion, respectively, and that the effects were additive.
Organic Solute-Coupled Na ؉ Transport. In addition to amiloride-sensitive Na ϩ channels, electrogenic Na ϩ transport across the ocular surface, and thus fluid secretion, may also involve Na ϩ -glucose and Na ϩ -amino acid cotransport. Figure  6A (left) shows that isosmolar addition of D-glucose but not of D-mannitol produced a small hyperpolarization that was reversed by the Na ϩ -glucose cotransporter inhibitor phloridzin.
L-Glucose (5 mM) produced no significant change in PD (data not shown, n ϭ 4 eyes). Under physiological conditions of high apical Na ϩ concentration, extracellular D-glucose saturability (K m ) was 2.5 mM as measured from PDs at increasing concentrations of D-glucose (Fig. 6A, middle and right) . Hill analysis gave a D-glucose-Na ϩ coupling ratio of 0.89, consistent with 1:1 Na ϩ -glucose cotransport. The PD data in Figure 6A were modeled to determine the turnover rates of transporters 2 and 9 (see Appendix for explanation of parameter selection). Modeling of the experimentally measured ϳ4-mV hyperpolarization under conditions of saturated cotransport and tonic ENaC inhibition (Fig. 6B ) indicated a J 2 (SGLT-1) turnover equal to ϳ75% of the J 1 (ENaC) basal activity (0.11 vs. 0.15 eq/cm 2 per hour). Because SGLT-1 likely transports two solutes per turnover, this implies similar osmolar absorptive capacities of amiloride-insensitive and amiloride-sensitive pathways.
The basic and neutral amino acids L-arginine and glycine also produced small, reversible hyperpolarizations in the presence of Na ϩ (Fig. 6C) . Amino acid transport was saturated only at relatively high concentration (several mM) for both amino acids studied. L-Arginine and glycine, added at 10 mM, yielded hyperpolarizations of 1.5 Ϯ 0.9 mV (n ϭ 4, SE) and 2.1 Ϯ 0.4 mV (n ϭ 5), respectively. PD analysis also revealed competitive substrate binding, where addition of L-arginine to glycine-containing solution reproducibly caused a depolarization (Fig. 6C,  right) . The Na ϩ dependence of these electrogenic pathways of glucose and amino acid absorption was confirmed. Figure 6D (left) shows hyperpolarizations produced by 5 mM D-glucose and 1 mM L-arginine (but not mannitol) in the presence of Na ϩ and amiloride. The hyperpolarizations were abolished after Na ϩ replacement by choline. Averaged results are summarized in Figure 6D (right). Together, these results provide evidence for at least three distinct electrogenic Na ϩ pathways at the ocular surface: amiloride-sensitive Na ϩ channels, Na ϩ -glucose cotransport, and Na ϩ -amino acid cotransport.
DISCUSSION
The goals of this study were to identify experimentally and to quantify by modeling the major Na ϩ -transporting pathways at the ocular surface and to use experimental and modeling results to examine the roles of epithelial transporters in driving Fig. 3A) . CFTR activation was produced by a threefold increase in apical Cl Ϫ permeability. (B) Simulation of protocol for studying sodium transport. Comparison of wild-type versus CF mouse ocular PDs in response to amiloride and then low Cl Ϫ . Solutions simulated: 1 alone, 1ϩamiloride, and 5ϩamiloride. CF mouse apical Cl Ϫ permeability was 20% of that in wild-type mouse, whereas apical Na ϩ permeability was not changed in the CF mouse parameter set. (C) Incremental steady state water secretion (above baseline), modeled in response to addition to solution 1 of amiloride, a CFTR activator (increasing apical Cl Ϫ conductance threefold), or both together.
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fluid secretion and putative CFTR-ENaC interactions. This approach provides a framework to define electrochemical coupling relevant to a variety of epithelial disorders, and for ocular surface epithelium, this approach allowed us to predict computationally the efficacy of therapies for states of tear deficiency. The PD measurement method is technically simple and permits minimally invasive in vivo measurements under physiological open-circuit conditions. The high-resistance epithelial surface, comprising cornea and conjunctiva in parallel, is responsible for generating and maintaining a large PD. The dependence of ocular PDs on specific Na ϩ and Cl Ϫ transport processes, combined with transport agonist-inhibitor and ion substitution maneuvers, allows for rapid qualitative assessment of solute transport in vivo. In this study, we extended the PD measurement concept by developing a mathematical model to rigorously relate measured PDs to transporter permeabilities and transporting mechanisms.
A major role for amiloride-sensitive apical Na ϩ absorption was found, which, according to the model, was equal in magnitude to total net Cl Ϫ secretion. The inhibitory half-concentrations of amiloride (K i , 0.82 mM) and benzamil (K i , 0.22 mM) measured are in close agreement with those reported recently in primary cultures of pigmented rabbit corneal epithelial cells 8 and are consistent with the greater potency of benzamil than amiloride for ENaC. Comparable depolarizations were observed for Na ϩ replacement and amiloride application in both wild-type and CF mice, suggesting that amiloride-sensitive Na ϩ conductance provides the primary route for apical membrane Na ϩ transport under the experimental conditions (solution 1, which lacks D-glucose and amino acids). Modeling of fluid secretion in the absence of an ionic gradient predicted that Na ϩ channel inhibition or CFTR Cl Ϫ channel activation would increase fluid secretion into the tear film and that both together would provide an even greater benefit than either strategy alone.
In contrast to the large measured apical Na ϩ conductance, a weak dependence of ocular surface PD on perfusate K ϩ concentration was found in the presence of amiloride, indicating a relatively small apical surface K ϩ conductance. Similar results were reported for human nasal epithelia. 19 At steady state, basolateral K ϩ channels enhance the electrochemical driving force for fluid secretion. However, modeling of PDs in this study predicted that increased basolateral K ϩ conductance would augment apical Cl Ϫ secretion little, suggesting that CFTR-specific activators would be as effective as general cAMP agonists (which activate CFTR and some basolateral K ϩ channels) in increasing apical chloride-driven fluid secretion.
Ocular surface PD measurements also provided direct evidence for transepithelial glucose-and amino acid-coupled Na ϩ absorption. The kinetics of substrate activation for the Na ϩ -glucose cotransporter (SGLT-1) varies widely among species. 20 Whereas tear Na ϩ concentration (Ͼ100 mM) is thought to provide a saturating concentration for Na ϩ (K m ϳ 60 mM), the affinity of SGLT-1 for glucose must be determined experimentally for a given system. The K m of 2.5 mM for glucose measured in this study is lower than that of 16.7 mM measured in rabbit conjunctiva. 18 The relatively low concentration of glucose in the normal human tear film (ϳ200 M) is unlikely to cause significant fluid absorption. 20 However, elevated tear glucose may contribute to the ocular surface disease noted in hyperglycemic diabetes (ϳ1 mM) by producing net absorption in the steady state. 21, 22 This prediction is supported by data in rabbits obtained by Shiue et al., 23 who found a ϳ75% reduction in transconjunctival fluid secretion upon apical addition of saturating glucose. Na ϩ -dependent neutral-basic amino acid cotransport has also been characterized in rabbit conjunctiva, where both high (micromolar K m )-and low (millimolar K m )-affinity processes have been described for L-arginine. 17 We measured qualitatively significant absorption at superphysiologic (in millimolar) amino acid concentrations, compared with the low-micromolar values reported by Puck et al. 24 in native tear film. Thus, although Na ϩ -coupled amino acid cotransport may not be relevant to steady-state tear fluid balance, our results support the strategy of delivering ocular therapeutics, either as amino acid analogues or conjugates, through cotransporters. 25 Although both corneal and conjunctiva epithelia are complex multilayered tissues, the ocular surface epithelial cell is modeled in the current study as a single cell layer with a parallel shunt, as was done previously to study passive solute fluxes across corneal epithelium. 26 Measurements in rabbit corneal epithelium have documented intimate electrical connection among superficial and wing cell layers, in support of this assumption. 27 Moreover, the apical superficial cell membrane largely dictates the electrical properties of stratified ocular surface epithelia because of its highly resistive tight junctions. 27, 28 The magnitudes of flux chosen in this simulation yielded a TEER of 5.3 k⍀/cm 2 , between the range of 12 to 17 k⍀/cm 2 measured under short-circuit conditions in rabbit cornea 5, 29 and that of 1 to 2 k⍀/cm 2 reported in rabbit conjunctiva. 6, 17, 25 A potential weakness of the current model is the simplistic consideration of paracellular conductances in the context of a complicated multilayered epithelium, where possible unstirred layers could affect intercellular solute movement. In polarized epithelia that can both absorb and secrete ions to comparable extents, such as those lining the ocular surface, relative paracellular ion conductances largely determine the degree of basal fluid absorption and secretion. 29 However, the treatment of paracellular conductance would only affect estimates of basal fluid secretion and not predictions regarding the utility of membrane-transport modulators. Relative impermeant-to-permeant paracellular ion permeabilities of 0.7 were selected for anions and cations, to reproduce the minimal effect of Na ϩ replacement by choline or K ϩ in the presence of amiloride. Of note, these parameters are also in accord with the measurements of Amasheh et al. 30 As has been found in nasal PD measurements in CF versus wild-type mice 31, 32 and CF versus non-CF human subjects, 19 amiloride produced a much greater depolarization at the ocular surface in CF versus wild-type mice (seen in Fig. 3 ). We also found an enhanced depolarization in CF mice after Na ϩ replacement. There is ongoing controversy regarding the mechanism responsible for these apparent CFTR-ENaC interactions. Whereas some studies have suggested direct inhibition of ENaC function by CFTR, 10,33 recent modeling and careful experimentation suggest that electrochemical coupling accounts for the apparent hyperabsorption of Na ϩ across CF epithelia. 11, 34 We investigated purported CFTR-ENaC interactions by modeling the system with parameters for CF mice chosen to test whether enhanced Na ϩ absorption across CF epithelia can be explained by electrochemical coupling between parallelfunctioning transporters. PDs from the CF mouse ocular surface were accurately simulated with fivefold reduced apical Cl Ϫ conductance, yet identical Na ϩ conductance, compared with wild-type mice, indicating that direct regulation of ENaC by CFTR by a mechanism other than electrochemical coupling is not necessary to explain the experimental results. Although CF epithelia are predicted to have 20% of normal function, both experiments and modeling suggest that most of the unstimulated (cAMP-and Ca 2ϩ -independent) Cl Ϫ flux passes through CFTR-dependent channels, though not through CFTR itself. We showed previously that the low-Cl Ϫ hyperpolarization in wild-type mice was reversed only to a small extent by a CFTR inhibitor. 4 Our model also demonstrated that reduced apical Cl Ϫ conductance and unaltered Na ϩ absorptive capacity were both necessary to abolish most of the low Cl Ϫ effect in CF mice (2.1-mV hyperpolarization predicted in CF as found experimentally).
In conclusion, our results define quantitatively the principal Na ϩ -transporting pathways at the ocular surface and the electrochemical coupling between Na ϩ and Cl Ϫ transport in wildtype and CF ocular surface epithelia. The model predicted significant enhancement of serosal-to-mucosal fluid transport by Na ϩ channel inhibitors and Cl Ϫ channel activators. Direct measurement of fluid secretion across the intact ocular surface and studies in animal models of dry eye syndrome are needed to guide and validate the modeling of fluid secretion. * Organic (D-glucose) was absent from most apical perfusates but was included at 30 mM when calculating P 2 and P 9 . 
